Serum Direct Bilirubin and Hemoglobin A1c Predict Cognitive Impairment After Diabetes Mellitus Combined with Cerebral Infarction

Key Points

• The research aims to determine the predictive value of serum direct bilirubin and hemoglobin A1c for cognitive impairment in patients with diabetes and cerebral infarction.
• Analyzed serum bilirubin and HbA1c levels in patients
• Assessed cognitive function using appropriate assessments
• Correlated levels with severity of cognitive impairment
• Low direct bilirubin levels are associated with higher cognitive impairment
• High hemoglobin A1c levels correlate positively with cognitive deficits
• Both biomarkers are independent risk factors for cognitive decline